Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs AMCR✓SelectedUSD · AMCRGSK vs AMCR performance historyLatest closeAs of-2.32%11/17
Stock and ETF performance explorer

GSK vs AMCR

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+43.0%
AMCR return
-8.9%
Excess return
+51.8%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioAMCRExcessAlpha
1D-2.3%-0.7%-1.6%-2.1%
7D-3.0%-3.9%+0.8%-1.8%
30D+0.4%-0.9%+1.3%+0.6%
3M-1.2%-3.2%+2.0%-0.3%
6M+0.9%+22.1%-21.2%-5.3%
YTD+4.0%+8.9%-4.9%+0.5%
1Y+7.3%+9.1%-1.8%+3.6%
3Y+57.1%+9.3%+47.8%+49.5%
5Y+43.0%-8.1%+51.1%+41.6%
All+43.0%-8.9%+51.8%+41.6%

Cumulative growth

Daily Returns

Daily percentage return beside AMCR.

Daily Out/Under-Performance

Portfolio return minus AMCR return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × AMCR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded AMCR wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling